The FDA's Position on Compounded GLP-1 Medications The FDA has specifically addressed compounded versions of semaglutide and tirzepatide
There is insufficient information to characterize the effects of anti-semaglutide antibodies on pharmacodynamics, safety or effectiveness of semaglutide
141 Common side effects include gastrointestinal reactions, such as nausea and vomiting, which are typically more common during the initial stages of treatment
Is the Medication Still Good If It Looks Cloudy or Has Particles
Because commercial pens come in fixed doses, microdosing protocols generally require a patient-specific compounded formulation prepared by a sterile, USP 797-compliant compounding pharmacy, supported by a documented clinical rationale
Reconstitution at a Glance The most common research-protocol approach for a 30mg vial: add 3.0mL bacteriostatic water to produce a 10mg/mL working concentration